1,727 research outputs found

    Anaerobic Co-digestion of Chlorella vulgaris and Dairy Whey for Enhanced Methane Production

    Get PDF
    The anaerobic digestion process is an additional step that can be implemented at wastewater treatment facilities for the production of biogas (i.e. methane) that can be used to generate energy and significantly reduce the facility\u27s energy cost. An emerging area of interest with anaerobic digestion is the inclusion of high-strength degradable organic waste (in addition to wastewater solids) that can lead to increased methane production by methanogens. Chlorella vulgaris (C. vulgaris), a species of green microalgae, is ubiquitous green alga often present at water-water treatment plants. I investigated its usefulness in an existing wastewater treatment process. Two investigations were conducted, the first to investigate the biomass growth potential of C. vulgaris in wastewater (primary clarifier and secondary clarifier effluents) and associated nutrient (ammonia and phosphorus) uptake, and the second to investigate the potential for methanogens to produce methane-rich biogas from anaerobic co-digestion of C. vulgaris with dairy whey. I hypothesized that (1) C. vulgaris would grow well in both wastewater effluents, but achieve the greatest total biomass production when cultured in primary clarifier effluent; and (2) including C. vulgaris in the anaerobic digestion of wastewater solids and dairy whey (i.e. co-digestion) would result in the production of biogas volumes greater than that produced from the digestion of only wastewater solids and only dairy whey. A growth experiment was conducted to measure algal biomass growth in primary and secondary clarifier effluents, and an anaerobic digestion trial was conducted to measure biogas volume and composition (% of methane). Both hypothesis were supported by the results. The most biomass production was observed in primary clarifier wastewater effluent (605 mg/L). The highest volumes (827 ml) and methane concentrations (56.8%) were obtained from anaerobic co-digestion of 32 ml (48% feed ratio) C. vulgaris (15 mg/L volatile solids) with 32 ml (48% feed ratio) of dairy whey (~1000 mg/L volatile solids). The data from the anaerobic digestion experiment was used to calculate potential savings at an existing wastewater treatment facility. The results indicated that including C. vulgaris in the anaerobic co-digestion of wastewater solids and a high-strength organic feedstock (i.e. dairy whey) could result in significant financial savings to wastewater treatment systems with anaerobic digesters. Further site-specific studies are needed to determine more accurately what the maximum digester loading rates of Chlorella and dairy whey (or other high-organic strength feedstocks) are, and subsequent methane production and energy savings

    Self Management Activation Randomised Trial for Prostatitis (SMART-P): study protocol for a randomised controlled trial

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Chronic prostatitis otherwise known as chronic pelvic pain syndrome is a common urological diagnosis that causes many men significant morbidity and has a detrimental effect on their quality of life. Standard treatment with antibiotics and simple analgesia are often ineffective and many patients are managed by the chronic pain services.</p> <p>Cognitive behavioural therapy has been shown to be helpful in the management of many chronic diseases and has recently been proposed as an effective treatment for chronic prostatitis. Furthermore, a self management programme administered to groups of men with lower urinary tract symptoms has been shown to be more effective than standard treatments including surgery.</p> <p>Therefore, we have developed a cognitive behavioural therapy programme specifically for men with chronic prostatitis. This novel treatment approach will be compared to conventional therapy in the pain clinic such as atypical analgesia and local anaesthetic injections in the context of a randomised controlled trial.</p> <p>Methods/Design</p> <p>Men will be recruited from general urology outpatient clinics following the exclusion of other diagnoses that could be responsible for their symptoms. Men will be randomised to attend either a self management healthcare and education programme or to pain clinic referral alone. The self management programme will be administered by a clinical psychologist to small groups of men over six consecutive weekly sessions each lasting two hours. Patients will be taught techniques of problem-solving and goal-setting and will learn coping mechanisms and how to modify catastrophic cognition.</p> <p>The primary outcome will be change from baseline in the National Institute of Health Chronic Prostatitis Symptom Index, a validated instrument for the assessment of men with chronic prostatitis. Secondary outcomes include generic quality of life scores and analgesic and drug usage. Outcomes will be assessed at 2, 6 and 12 months.</p> <p>Discussion</p> <p>If this group administered self management programme is shown to be effective in the treatment of men with chronic prostatitis it may become the new standard of care for these patients. Furthermore, it may be adapted for use in women with interstitial cystitis, a condition which is analogous to chronic prostatitis in men.</p> <p>Trial Registration</p> <p>Current Controlled Trials <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=ISRCTN21012555">ISRCTN21012555</a></p

    Gold nanoparticles and diclofenac diethylammonium administered by iontophoresis reduce inflammatory cytokines expression in Achilles tendinitis

    Get PDF
    Marcelo B Dohnert1,2, Mirelli Ven&amp;acirc;ncio1, Jonathann C Possato1, Rodrigo C Zeferino1, Luciana H Dohnert2, Alexandra I Zugno1, Cl&amp;aacute;udio T De Souza1, Marcos MS Paula1, Thais F Luciano11Postgraduation Program in Health Sciences, Programa de P&amp;oacute;s-gradua&amp;ccedil;&amp;atilde;o em Ci&amp;ecirc;ncias da Sa&amp;uacute;de PPGCS, Universidade do Extremo Sul Catarinense, Crici&amp;uacute;ma, Santa Catarina, 2Department of Physiotherapy, Universidade Luterana do Brasil, Torres, Rio Grande do Sul, BrazilIntroduction: Tendinitis affects a substantial number of people in several occupations involving repetitive work or direct trauma. Iontophoresis is a therapeutic alternative used in the treatment of injury during the inflammatory phase. In recent years, gold nanoparticles (GNP) have been studied due to their therapeutic anti-inflammatory capacity and as an alternative to the transport of several proteins. Purpose: This study evaluates the therapeutic effects of iontophoresis using GNPs and diclofenac diethylammonium on inflammatory parameters in rats challenged with traumatic tendinitis.Methods: Wistar rats were divided in three treatment groups (n = 15): (1) iontophoresis + diclofenac diethylammonium; (2) iontophoresis + GNP; and (3) iontophoresis + diclofenac diethylammonium + GNP. External control was formed by challenged tendons without treatment (n = 15). Iontophoresis was administered using 0.3 mA direct current on 1.5 cm&amp;sup2; electrodes. Results: The levels of both inflammatory cytokines were significantly higher in untreated challenged rats, when compared with the control (5.398 &amp;plusmn; 234 for interleukin 1 beta and 6.411 &amp;plusmn; 432 for tumor necrosis factor alpha), which confirms the occurrence of an inflammatory stage in injury (P &amp;lt; 0.05). A significant decrease was observed in expression of cytokines interleukin 1 beta in the three treatment groups, in comparison with untreated challenged tendons, although, in the group treated with diclofenac and GNP, results were similar to the control (1.732 &amp;plusmn; 239) (P &amp;lt; 0.05). Concerning tumor necrosis factor alpha, only the group treated with the association diclofenac and GNPs presented decreased levels, compared with the control (3.221 &amp;plusmn; 369) (P &amp;lt; 0.05). Conclusion: The results show the efficacy of drug administration using direct current to treat tendinitis in an animal model, and the potential anti-inflammatory, carrier, and enhancing effects of GNPs in iontophoresis.Keywords: tendinous injury, proinflammatory cytokines, electrophoresis, iontophoresis, nanoparticle

    Virtual Community Health Workers: Outreach Calls During COVID-19

    Get PDF
    The “Clinical Experience” program at the Sidney Kimmel Medical College, established in 2017, provides pre-clerkship students with an opportunity to identify and address patients’ needs for social determinants of health (SDoH). The COVID-19 pandemic led to a suspension of the student program in the clinical environment, but the CHWs continued to address patients’ social needs from a remote setting. In the absence of established best practices regarding patient outreach calls from a remote setting, we sought to develop an effective workflow that would mask the CHWs’ personal cell phones while leading to fewer “unable to reach” scenarios and improved case resolution rates

    TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson's Disease.

    Get PDF
    Alpha-synuclein (α-Syn) accumulation/aggregation and mitochondrial dysfunction play prominent roles in the pathology of Parkinson's disease. We have previously shown that postmortem human dopaminergic neurons from PD brains accumulate high levels of mitochondrial DNA (mtDNA) deletions. We now addressed the question, whether alterations in a component of the mitochondrial import machinery -TOM40- might contribute to the mitochondrial dysfunction and damage in PD. For this purpose, we studied levels of TOM40, mtDNA deletions, oxidative damage, energy production, and complexes of the respiratory chain in brain homogenates as well as in single neurons, using laser-capture-microdissection in transgenic mice overexpressing human wildtype α-Syn. Additionally, we used lentivirus-mediated stereotactic delivery of a component of this import machinery into mouse brain as a novel therapeutic strategy. We report here that TOM40 is significantly reduced in the brain of PD patients and in α-Syn transgenic mice. TOM40 deficits were associated with increased mtDNA deletions and oxidative DNA damage, and with decreased energy production and altered levels of complex I proteins in α-Syn transgenic mice. Lentiviral-mediated overexpression of Tom40 in α-Syn-transgenic mice brains ameliorated energy deficits as well as oxidative burden. Our results suggest that alterations in the mitochondrial protein transport machinery might contribute to mitochondrial impairment in α-Synucleinopathies

    Targeted knock-down of miR21 primary transcripts using snoMEN vectors induces apoptosis in human cancer cell lines

    Get PDF
    We have previously reported an antisense technology, 'snoMEN vectors', for targeted knock-down of protein coding mRNAs using human snoRNAs manipulated to contain short regions of sequence complementarity with the mRNA target. Here we characterise the use of snoMEN vectors to target the knock-down of micro RNA primary transcripts. We document the specific knock-down of miR21 in HeLa cells using plasmid vectors expressing miR21-targeted snoMEN RNAs and show this induces apoptosis. Knock-down is dependent on the presence of complementary sequences in the snoMEN vector and the induction of apoptosis can be suppressed by over-expression of miR21. Furthermore, we have also developed lentiviral vectors for delivery of snoMEN RNAs and show this increases the efficiency of vector transduction in many human cell lines that are difficult to transfect with plasmid vectors. Transduction of lentiviral vectors expressing snoMEN targeted to pri-miR21 induces apoptosis in human lung adenocarcinoma cells, which express high levels of miR21, but not in human primary cells. We show that snoMEN-mediated suppression of miRNA expression is prevented by siRNA knock-down of Ago2, but not by knock-down of Ago1 or Upf1. snoMEN RNAs colocalise with Ago2 in cell nuclei and nucleoli and can be co-immunoprecipitated from nuclear extracts by antibodies specific for Ago2
    corecore